Amount Of P30 Research Articles

Isolation and characterization of a monoclonal anti-P30 antibody resistant mutant of Toxoplasma gondii.

Of the possible iodine-labelled Toxoplasma gondii surface proteins, P30 (apparent Mr 30,000) is the principal one recognized by acute and convalescent anti-toxoplasma sera. This protein which comprises from 3 to 5% of the total parasite protein was used to raise a panel of parasiticidal monoclonal anti-P30 antibodies. One of these monoclonal antibodies was able to select a resistant mutant from a large population of chemically mutagenized wild-type P strain parasites. This mutant retained the wild type sensitivity to other non-P30 parasiticidal monoclonal antibodies as well as polyclonal anti-P30 rabbit sera. Analysis of surface radioiodinated wild type and mutant parasites showed that the mutant had a quantitative reduction in the amount of P30. A comparison of surface biotin labelled wild type and resistant parasites by two dimensional electrophoresis showed that the mutant lacked one and possibly two of several proteins that make up wild type P30. Western blot analysis indicated that the mutant was devoid of antigenically reactive P30. These findings further support the hypothesis that antigenic variants of T. gondii can be induced and may involve the major surface membrane antigens of the parasite.

Restriction of C-type viral antigen in H-2/Fv-1 syngeneic mouse somatic cell hybrids.

Somatic cell hybrids between an AKR lymphoma or a C3H sarcoma and H-2, Fv-1 syngeneic CBA sarcoma or carcinoma have been examined for expression of the structural components of murine leukemia virus (MuLV) by radioimmunoassay and complement-dependent cytotoxicity assay. Parental AKR and C3H cells contained high concentrations of MuLV core protein p30 in their cell extracts and showed high sensitivity to anti-MuLVgp70 and p30 sera. In contrast, CBA cells expressed little detectable p30 in the extracts, were much less sensitive to anti-gp70 serum, and were almost insensitive to anti-p30 serum. The hybrids between the AKR or C3H cells and CBA cells had a decreased amount of p30 in the extracts and were almost resistant to cytotoxicity by anti-p30 serum, although they maintained high sensitivity to anti-gp70 serum. These findings suggest that the CBA genotype suppresses the production and cell-surface expression of p30 antigen of AKR and C3H endogenous C-type viruses. The suppressive gene is not Fv-1n.

Co-regulation of type C RNA virus production and cell differentiation in myeloid leukemic cells

Mouse myeloid leukemic cells which differ in their competence to be induced to differentiate by the normal macrophage- and granulocyte-inducing protein MGI have been used to study the relationship between type C RNA virus production and myeloid cell differentiation. Clones which can be induced by MGI to form Fc and C3 rosettes, to synthesize and secrete lysozyme and to differentiate to mature macrophages and granulocytes (MGI +D +) were induced by MGI to produce higher amounts of type C virus. Clones (MGI +D −) that were less inducible by MGI for Fc and C3 rosettes and lysozyme and were not induced to form mature cells were also less inducible for higher virus production. In both types of clones, the increased virus production induced by MGI preceded the induction of rosettes and lysozyme. Clones that were not induced by MGI for rosettes or lysozyme (MGI −D −) showed little or no enhancement of virus production. MGI did not affect virus production in erythroleukemic cells, and erythropoietin did not affect virus production in the myeloid leukemic cells. Dexamethasone, lipopolysaccharide, dimethylsulfoxide and low concentrations of actinomycin D can induce some differentiation-associated properties in some of the clones. With these compounds, there was also a direct relationship between the enhancement of virus production and induction of differentiation-associated properties. Virus released from the three types of clones before or after treatment with MGI or dexamethasone was identified as N-tropic. The enhancement of virus production, as measured by reverse transcriptase activity, was accompanied by an increase in the amount of the viral protein p30, and interferon, which did not inhibit the induction of differentiation in the myeloid leukemic cells, also did not prevent the increase in the amount of p30. After the early enhancement of virus production associated with the induction of differentiation, a shut-off of virus production occurred in the mature cells induced by MGI in MGI +D + clones, whereas clones that did not differentiate to mature cells continued to produce virus. The results indicate that enhancement of virus production appears to be an early step in the induction of differentiation. Once induction has occurred, the lack of virus production in the mature cells suggest that a subsequent shut-off of virus production may be required for the completion of differentiation to mature cells. This relationship between cell differentiation and virus production suggests that type C virus has a regulatory role in myeloid cell differentiation.

Purification and characterization of a murine tumor cell surface glycoprotein of 75,000 daltons that is related to the major envelope glycoprotein of murine leukemia virus

An antigen which competes with murine C-type viral glycoprotein in an interspecies radioimmunocompetition assay has been purified from the surface of EL-4 tumor cells. The EL-4 tumor cell is virus particle negative. The amount of p30 was extremely low and there was no detectable p12 or p15, confirming that the tumor cell was not expressing a murine oncornavirus. In homologous competition radioimmunoassays, the tumor cell was negative for Rauscher and AKR gp71, but in an interspecies assay employing 125I-Rauscher gp71 and anti-feline leukemia virus serum, there was a reactive antigen. The gp71-like antigen was on the surface of the tumor cell since, by immunofluorescence and immunoelectronmicroscopy, the EL-4 cell could be labeled with antiserum against Rauscher virus gp71. The gp71 cross-reactive antigen was purified by lithium diiodosalycilate extraction, DEAF; chromatography, and lentil lectin affinity chromatography. It is a glycoprotein of about 75,000 daltons which could be precipitated by various broadly reactive antisera to murine gp71s and antisera to murine virus. Based on radioimmunocompetition assays, the purified gp75 was not related to AKR or Rauscher gp71, but did compete in an assay using BALB/2 xenotropic gp71 and anti-C57/L virus serum. It also competed in an assay using 125I-Moloney virus gp71 and anti-Moloney virus serum, but not in a more type-specific assay assay 125I-Moloney virus gp71 and anti-Moloney gp71 serum. Tryptic peptide maps of iodinated proteins were prepared and the cell surface antigen was compared with AKR gp71, Moloney gp71, Rauscher gp71, and xenotropic BALB/2 and NZB gp71s. The EL-4 gp75 was not identical with or very similar structurally to any of the viral gp71s. The differences in the structures of the various viral gp71s shown here and also in other laboratories are consistent with the idea that the env genes of murine viruses which code for gp71s are sites of frequent recombinational events. Recombination between different endogenous viral sequences or between viral and host allelic genomes could have resulted in many immunologically related proteins on viruses, cell surfaces and, in sera of mice, which are immunologically related, about 70,000-dalton molecular weight, but have divergent structure.